Your browser doesn't support javascript.
loading
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
Goetze, Thorsten O; Hofheinz, Ralf-Dieter; Gaiser, Timo; Schmalenberg, Harald; Strumberg, Dirk; Goekkurt, Eray; Angermeier, Stefan; Zander, Thomas; Kopp, Hans G; Pink, Daniel; Siegler, Gabriele; Schenk, Michael; de Vita, Ferdinando; Galizia, Gennaro; Maiello, Evaristo; Bechstein, Wolf O; Elshafei, Moustafa; Loose, Maria; Sookthai, Disorn; Brulin, Tanita; Pauligk, Claudia; Homann, Nils; Al-Batran, Salah-Eddin.
Afiliação
  • Goetze TO; Institute for Clinical Cancer Research IKF, Frankfurt, Germany.
  • Hofheinz RD; Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt, Germany.
  • Gaiser T; Mannheim Cancer Center, University Hospital Mannheim, Mannheim, Germany.
  • Schmalenberg H; Institute of Pathology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Strumberg D; IV. Medical Clinic (Friedrichstadt), Städtisches Klinikum Dresden, Dresden, Germany.
  • Goekkurt E; Department of Hematology and Oncology, Marienhospital Herne, University Bochum, Herne, Germany.
  • Angermeier S; Hematology-Oncology Practice, Specialist Center Eppendorf und University Cancer Center Hamburg (UCCH), Hamburg, Germany.
  • Zander T; Center for Palliative Care Ludwigsburg-Bietigheim, RKH Kliniken, Ludwigsburg, Germany.
  • Kopp HG; Internal Medicine I, University Hospital Köln, Köln, Germany.
  • Pink D; Robert Bosch Center for Tumor Diseases, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Siegler G; Sarcoma Center Berlin-Brandenburg, Helios Hospital Bad Saarow, Bad Saarow, Germany.
  • Schenk M; Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany.
  • de Vita F; Department of Internal Medicine, Hematology and Medical Oncology, Hospital Nürnberg/Paracelsus Medical University, Nürnberg, Germany.
  • Galizia G; Hospital Barmherzige Brüder Regensburg, Regensburg, Germany.
  • Maiello E; Division of Medical Oncology, Department of Precision Medicine, Università della Campania "Luigi Vanvitelli", Naples, Italy.
  • Bechstein WO; Division of Surgical Oncology, Università della Campania "Luigi Vanvitelli", Naples, Italy.
  • Elshafei M; Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Loose M; Department of General and Visceral Surgery, Frankfurt University Hospital, Frankfurt am Main, Germany.
  • Sookthai D; Krankenhaus Nordwest, UCT-University Cancer Center, Frankfurt, Germany.
  • Brulin T; Institute for Clinical Cancer Research IKF, Frankfurt, Germany.
  • Pauligk C; Institute for Clinical Cancer Research IKF, Frankfurt, Germany.
  • Homann N; Institute for Clinical Cancer Research IKF, Frankfurt, Germany.
  • Al-Batran SE; Institute for Clinical Cancer Research IKF, Frankfurt, Germany.
Int J Cancer ; 153(1): 153-163, 2023 07 01.
Article em En | MEDLINE | ID: mdl-36883420
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article